AmbroSpray ®

The only Oral Solution Spray formulation of Ambroxol for the mucolytic treatment of acute and chronic bronchopulmonary diseases characterized by impaired mucous formation and transportation. 1. UNIQUE & PATENTED formulation AmbroSpray® has a unique and patented formulation. 2. PRECISE Spray presentation with a pharmaceutical-metered pump that delivers exactly 10mg per spray pump. Allows the therapeutical dose of 90 mg per day (3 puffs 3 times per day). 3. HIGHEST CONCETRATION Only ambroxol with 5% concentration, Mucosolvan® has only 0,6%. 4. PRACTICAL and EASY TO USE Small bottle which can comfortably been carried and easily been used. 5. CLINICALLY PROVEN EFFICACY OF THE API Very well-known API with certified clinical effect. AmbroSpray® bioequivalence study vs. Mucosolvan® syrup.